Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 87.86M P/E - EPS this Y -61.50% Ern Qtrly Grth -
Income -9.73M Forward P/E 64.80 EPS next Y 46.00% 50D Avg Chg 7.00%
Sales 49.22M PEG -0.51 EPS past 5Y - 200D Avg Chg 21.00%
Dividend N/A Price/Book 18.95 EPS next 5Y 15.00% 52W High Chg -34.00%
Recommedations 3.00 Quick Ratio 0.56 Shares Outstanding 13.59M 52W Low Chg 73.00%
Insider Own 25.56% ROA -17.48% Shares Float 4.72M Beta 0.40
Inst Own 42.22% ROE -388.65% Shares Shorted/Prior 56.51K/62.58K Price 6.48
Gross Margin 40.09% Profit Margin -19.76% Avg. Volume 9,067 Target Price 6.00
Oper. Margin -21.44% Earnings Date Jul 22 Volume 7,138 Change 0.00%
About Champions Oncology, Inc.

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Champions Oncology, Inc. News
04/17/24 Will Champions Oncology (NASDAQ:CSBR) Spend Its Cash Wisely?
03/19/24 Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Call Transcript
03/12/24 Champions Oncology Reports Quarterly Revenue of $12.0 Million
03/07/24 Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
03/06/24 Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
03/05/24 Pleasing Signs As A Number Of Insiders Buy Champions Oncology Stock
12/14/23 Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Call Transcript
12/12/23 Champions Oncology Reports Quarterly Revenue of $11.6 Million
12/04/23 Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
11/15/23 The past three years for Champions Oncology (NASDAQ:CSBR) investors has not been profitable
07:30 AM Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
10/17/23 Champions Oncology Announces the Addition of Brady Davis as President
09/27/23 Favourable Signals For Champions Oncology: Numerous Insiders Acquired Stock
09/27/23 Champions Oncology Independent Director Acquires 14% More Stock
09/13/23 Champions Oncology Reports Quarterly Revenue of $12.6 Million
09/11/23 Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
08/22/23 Champions Oncology Announces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
08/01/23 Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
07/24/23 Champions Oncology Reports Quarterly Revenue of $13.1 Million
07/20/23 Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023
CSBR Chatroom

User Image Stock_Titan Posted - 03/12/24

$CSBR Champions Oncology Reports Quarterly Revenue of $12.0 Million https://www.stocktitan.net/news/CSBR/champions-oncology-reports-quarterly-revenue-of-12-0-dfd0gwz4nsij.html

User Image Stock_Titan Posted - 03/07/24

$CSBR Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation https://www.stocktitan.net/news/CSBR/champions-oncology-s-us-laboratory-has-acquired-distinguished-cap-wxicwilh03r8.html

User Image Stock_Titan Posted - 03/06/24

$CSBR Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024 https://www.stocktitan.net/news/CSBR/champions-oncology-to-announce-third-quarter-financial-results-on-bcp8b84u5qq2.html

User Image FHE_wizard Posted - 02/15/24

$CSBR something big out of the way - $ 9 by the end of Feb

User Image FHE_wizard Posted - 02/08/24

$CSBR imminent ascent in a sector whispered to redefine tomorrow

User Image Aigner_Andreas Posted - 01/31/24

TD BUY $CSBR at 5.81, Supp 5.81 Resis 6.91 R19 HiLo 55% T1Y 15 buy 2.0 DIV N/A #Champions #stocks #trading #finance #market

User Image cctranscripts Posted - 01/16/24

Champions Oncology director just picked up 1,000 shares https://www.conferencecalltranscripts.org/summary/?id=12868661 $CSBR

User Image risenhoover Posted - 01/16/24

Insider Daniel Newman Mendelson reports buying 1,000 shares of $CSBR for a total cost of $6,500.00 https://fintel.io/n/us/csbr/mendelson-daniel-newman?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image TonishaTsai Posted - 01/14/24

$CSBR $LEU $KINS $PHVS $REAX Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts.. Highly recommended! It's free joining.,,,,🍂👉 stocks-great-winning-trades-us-market.blogspot.com/2024/01/blog-post.html

User Image MollyCiotti Posted - 01/13/24

$ALRN $CSBR $LEU ACCOUNT CHALLENGE UPDATE: Starting Balance: $3,700 Current Balance: $54,873 Goal: $100K by end of Jan. Watch out for our next alert!.-;;'💖 top-stocks-winning-great-us.blogspot.com/2023/11/blog-post.html

User Image cctranscripts Posted - 01/12/24

Champions Oncology director just picked up 2,000 shares https://www.conferencecalltranscripts.org/summary/?id=12863522 $CSBR

User Image risenhoover Posted - 01/12/24

Insider Daniel Newman Mendelson reports buying 2,000 shares of $CSBR for a total cost of $12,540.00 https://fintel.io/n/us/csbr/mendelson-daniel-newman?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image cctranscripts Posted - 01/11/24

Champions Oncology director just picked up 2,944 shares https://www.conferencecalltranscripts.org/summary/?id=12860154 $CSBR

User Image risenhoover Posted - 01/11/24

Insider Daniel Newman Mendelson reports buying 2,944 shares of $CSBR for a total cost of $18,576.64 https://fintel.io/n/us/csbr/mendelson-daniel-newman?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image cctranscripts Posted - 01/10/24

Champions Oncology director just picked up 3,000 shares https://www.conferencecalltranscripts.org/summary/?id=12856606 $CSBR

User Image risenhoover Posted - 01/10/24

Insider Daniel Newman Mendelson reports buying 3,000 shares of $CSBR for a total cost of $18,750.00 https://fintel.io/n/us/csbr/mendelson-daniel-newman?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image StockAutomatePro Posted - 01/09/24

$CSBR The stock looks poised for growth based on the chart. We alerted the BUY signal at $5.65 and we were able to close this one with profit at $6.24 🔏

User Image cctranscripts Posted - 01/09/24

Champions Oncology director just picked up 1,000 shares https://www.conferencecalltranscripts.org/summary/?id=12853327 $CSBR

User Image risenhoover Posted - 01/09/24

Insider Daniel Newman Mendelson reports buying 1,000 shares of $CSBR for a total cost of $6,150.00 https://fintel.io/n/us/csbr/mendelson-daniel-newman?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image StockAutomatePro Posted - 01/08/24

$CSBR Looks like the stock is headed for a period of growth according to the chart. We alerted the BUY signal at $5.62 and we were able to close this one with profit at $6.14 📊 See more details at StockAutomate.com

User Image cctranscripts Posted - 01/08/24

Champions Oncology director just picked up 2,000 shares https://www.conferencecalltranscripts.org/summary/?id=12850816 $CSBR

User Image cctranscripts Posted - 01/08/24

Champions Oncology director just picked up 3,000 shares https://www.conferencecalltranscripts.org/summary/?id=12850766 $CSBR

User Image risenhoover Posted - 01/08/24

Insider Daniel Newman Mendelson reports buying 2,000 shares of $CSBR for a total cost of $12,180.00 https://fintel.io/n/us/csbr/mendelson-daniel-newman?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image risenhoover Posted - 01/08/24

Insider Daniel Newman Mendelson reports buying 3,000 shares of $CSBR for a total cost of $18,360.00 https://fintel.io/n/us/csbr/mendelson-daniel-newman?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image cctranscripts Posted - 01/05/24

Champions Oncology director just picked up 114,552 shares https://www.conferencecalltranscripts.org/summary/?id=12846523 $CSBR

User Image cctranscripts Posted - 12/26/23

Champions Oncology director just picked up 2,500 shares https://www.conferencecalltranscripts.org/summary/?id=12820440 $CSBR

User Image risenhoover Posted - 12/26/23

Insider Daniel Newman Mendelson reports buying 2,500 shares of $CSBR for a total cost of $12,300.00 https://fintel.io/n/us/csbr/mendelson-daniel-newman?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image cctranscripts Posted - 12/21/23

Champions Oncology director just picked up 2,100 shares https://www.conferencecalltranscripts.org/summary/?id=12814339 $CSBR

User Image risenhoover Posted - 12/21/23

Insider Daniel Newman Mendelson reports buying 2,100 shares of $CSBR for a total cost of $10,122.00 https://fintel.io/n/us/csbr/mendelson-daniel-newman?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image cctranscripts Posted - 12/20/23

Champions Oncology director just picked up 5,000 shares https://www.conferencecalltranscripts.org/summary/?id=12808851 $CSBR

Analyst Ratings
Craig-Hallum Hold Mar 13, 24
Roth MKM Buy Sep 22, 23
Roth Capital Buy Mar 15, 21
Benchmark Speculative Buy Nov 18, 19
Roth Capital Buy Sep 20, 19
Janney Montgomery Scott Neutral Jul 24, 19
Craig-Hallum Buy Jul 17, 18
Dawson James Buy May 15, 18
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Mendelson Daniel Newman Director Director Jan 12 Buy 6.50 1,000 6,500 198,625 01/16/24
Mendelson Daniel Newman Director Director Jan 11 Buy 6.27 2,000 12,540 197,625 01/12/24
Mendelson Daniel Newman Director Director Jan 10 Buy 6.31 2,944 18,577 195,625 01/11/24
Mendelson Daniel Newman Director Director Jan 09 Buy 6.25 3,000 18,750 192,681 01/10/24
Mendelson Daniel Newman Director Director Jan 08 Buy 6.15 1,000 6,150 189,681 01/09/24
Mendelson Daniel Newman Director Director Dec 21 Buy 4.92 2,500 12,300 183,181 12/26/23
Mendelson Daniel Newman Director Director Dec 20 Buy 4.82 2,100 10,122 180,681 12/21/23
Mendelson Daniel Newman Director Director Dec 19 Buy 4.75 5,000 23,750 178,581 12/20/23
Mendelson Daniel Newman Director Director Sep 29 Buy 6.16 4,000 24,640 173,581 10/16/23
Mendelson Daniel Newman Director Director Sep 28 Buy 6.22 5,000 31,100 169,581 10/16/23
Mendelson Daniel Newman Director Director Sep 27 Buy 5.95 1,500 8,925 164,581 10/16/23
Mendelson Daniel Newman Director Director Oct 11 Buy 6.40 5,000 32,000 163,081 10/13/23
Mendelson Daniel Newman Director Director Oct 06 Buy 6.48 1,530 9,914 156,981 10/10/23
Mendelson Daniel Newman Director Director Oct 05 Buy 6.47 2,000 12,940 155,451 10/06/23
Mendelson Daniel Newman Director Director Oct 03 Buy 6.30 2,500 15,750 148,451 10/04/23
Mendelson Daniel Newman Director Director Oct 04 Buy 6.40 5,000 32,000 153,451 10/04/23
Mendelson Daniel Newman Director Director Sep 26 Buy 5.65 5,000 28,250 145,951 09/27/23
Mendelson Daniel Newman Director Director Sep 19 Buy 5.28 5,000 26,400 128,121 09/25/23
Mendelson Daniel Newman Director Director Sep 20 Buy 5.51 4,018 22,139 132,139 09/25/23
Mendelson Daniel Newman Director Director Sep 21 Buy 5.51 5,000 27,550 137,139 09/25/23
Mendelson Daniel Newman Director Director Sep 22 Buy 5.50 3,812 20,966 140,951 09/25/23